Novartis plans to expand it’s R&D for innovative drugs in China, it’s expected that the company will submit 50 drug applications in the country and between 2019 and 2023.
Please follow and like us:
Novartis boosts drug R&D in China
Newest Articles
Renminbi Hub in Switzerland has 13 partner banks
In 2016, the China Construction Bank (CBC) established the Renminbi Hub in Switzerland and since then, is developing cross-border business with the currency in...
